Bank of America vs JPMorgan Chase
BAC and JPM side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BAC and JPM compare
JPMorgan Chase is the larger company, worth 2.6 times as much as Bank of America ($896B against $350B).
On earnings, Bank of America is cheaper: it trades at 11.9× trailing earnings, against 14.4× for JPMorgan Chase.
JPMorgan Chase grew revenue faster over the last twelve months (13.5% versus 5.4% for Bank of America).
JPMorgan Chase keeps more of each dollar of sales as profit, with a net margin of 32.6% compared with 26.8% at Bank of America.
Both pay dividends: Bank of America yields 2.3% and JPMorgan Chase 1.8%.
JPMorgan Chase scores higher on the StockData Score (17 against 12 for Bank of America), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BAC | JPM |
|---|---|---|
| Size and price | ||
| Market cap | $350B | $896B |
| Share price | $50.01 | $337.04 |
| Change, 1 year | −4.9% | 10.3% |
| Change, 5 years | 6.5% | 101% |
| Beta (5Y) | 1.11 | 1.01 |
| Employees | 213K | 319K |
| StockData Score | ||
| Total score | 12 | 17 (better) |
| Valuation score | 5 (better) | 0 |
| Growth score | 0 | 4 (better) |
| Performance score | 1 | 5 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 11.9× (better) | 14.4× |
| P/S | 2.9× (better) | 4.5× |
| P/B | 1.2× (better) | 2.4× |
| PEG | 1.95 | 0.79 (better) |
| Fair value | $51.52 | $246.53 |
| Margin of safety | 2.9% (better) | −36.7% |
| Growth | ||
| Revenue growth (TTM) | 5.4% | 13.5% (better) |
| Revenue growth, 5Y average | 5.7% | 8.7% (better) |
| Net income growth (TTM) | 9.8% | 15.1% (better) |
| EPS growth (TTM) | 15.7% | 19.8% (better) |
| EPS growth, 5Y average | 15.3% | 17.7% (better) |
| Profitability | ||
| Net margin | 26.8% | 32.6% (better) |
| Return on equity | 10.8% | 17.8% (better) |
| Financial health | ||
| Debt / equity | – | 0.19 |
| Altman Z-score | 0.22 | 0.28 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 2.3% (better) | 1.8% |
| Payout ratio | – | 26.6% |
| Years of dividend growth | 12 | 15 (better) |
| Dividend growth, 5Y average | 8.4% | 10.0% (better) |
| Buyback yield | 7.3% (better) | 3.5% |
| Shareholder yield | 9.6% (better) | 5.4% |
| Ownership | ||
| Held by institutions | 76.8% | 74.7% |
| Held by insiders | 0.15% | 0.37% |
| Insider net buying, 12 months | −$31.1M (better) | −$126M |
| Superinvestors holding | 8 | 10 (better) |
Go deeper
- BAC stock overview
- BAC income statement
- BAC valuation and score
- JPM stock overview
- JPM income statement
- JPM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.